SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,983 | -11.7% | 21,472 | -3.8% | 0.09% | -5.5% |
| Q2 2023 | $670,609 | -17.0% | 22,309 | 0.0% | 0.09% | -38.1% |
| Q1 2023 | $808,255 | +1.6% | 22,309 | 0.0% | 0.15% | -3.3% |
| Q4 2022 | $795,762 | -6.5% | 22,309 | +4.5% | 0.15% | +23.6% |
| Q4 2017 | $851,000 | -0.4% | 21,344 | 0.0% | 0.12% | -3.1% |
| Q3 2017 | $854,000 | -7.2% | 21,344 | 0.0% | 0.13% | -67.7% |
| Q2 2017 | $920,000 | +1252.9% | 21,344 | +888.6% | 0.39% | +379.3% |
| Q1 2017 | $68,000 | -99.9% | 2,159 | 0.0% | 0.08% | -91.7% |
| Q4 2016 | $54,514,000 | – | 2,159 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |